At ISNTD d³ 2017, Dr. Benny Baeten, Compound Development Team Leader Anthelmintics at Janssen Pharmaceutica (a J&J Global Health company) speaks about J&J's commitment to delivering the pledges of the 2012 London Declaration on NTDs, including current developments in antihelminthics research and partnerships.